Go Pro
CVE:MDX

MedX Health (MDX) Stock Price, News & Analysis

MedX Health logo
C$0.04 -0.01 (-10.00%)
As of 02:16 PM Eastern

About MedX Health Stock (CVE:MDX)

Advanced

Key Stats

Today's Range
C$0.05
C$0.05
50-Day Range
C$0.05
C$0.06
52-Week Range
C$0.04
C$0.07
Volume
6,000 shs
Average Volume
86,563 shs
Market Capitalization
C$14.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

Receive MDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedX Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDX Stock News Headlines

Do NOT Buy the Next $2 Trillion IPO Before Reading This
Anthropic is reportedly preparing to file its IPO prospectus shortly after Labor Day, with a potential valuation as high as 2 trillion dollars. Before the headlines and hype hit, Michael Robinson says there is something investors should understand first, what he calls the Big IPO Lie. He has uncovered a different way to look at Anthropic's move ahead of its public debut.tc pixel
MedX Health 2025 YEAR REVIEW
Off-market insider buying at MedX Health (MDX)
See More Headlines

MDX Stock Analysis - Frequently Asked Questions

MedX Health's stock was trading at C$0.06 at the beginning of the year. Since then, MDX shares have decreased by 18.2% and is now trading at C$0.05.

Shares of MDX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that MedX Health investors own include Enterprise Products Partners (EPD), JOY (JOY), Health Care Select Sector SPDR Fund (XLV), Medical Facilities (DR), Omega Healthcare Investors (OHI) and Alimentation Couche-Tard (ATD.B).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
CVE:MDX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.68
P/E Growth
N/A
Net Income
-C$3.82 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-220.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.10
Quick Ratio
0.05

Sales & Book Value

Annual Sales
C$569.79 thousand
Price / Sales
25.90
Cash Flow
C$0.00 per share
Price / Cash Flow
60.00
Book Value
C($0.03) per share
Price / Book
-1.50

Miscellaneous

Outstanding Shares
327,932,000
Free Float
N/A
Market Cap
C$14.76 million
Optionable
Not Optionable
Beta
0.34
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (CVE:MDX) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners